Somatic mutations precede acute myeloid leukemia years before diagnosis
Pinkal Desai(NewYork–Presbyterian Hospital), Duane C. Hassane(AstraZeneca (Singapore)), Gloria Cheang(Cornell University), Gail J. Roboz(Cornell University), Nuria Mencia-Trinchant(NewYork–Presbyterian Hospital), Mónica L. Guzmán(NewYork–Presbyterian Hospital), Karla V. Ballman(Mayo Clinic in Arizona), Ellen K. Ritchie(Cornell University), Oleksandr Savenkov(Cornell University), Sang‐Min Lee(Seoul National University), Michael Samuel(NewYork–Presbyterian Hospital), Michael S. Simon(Exponent (United States))
Cited by 621
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k